Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to $24.1 million.

  • Definitive Healthcare's Cash from Investing Activities rose 16940.07% to $24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.3 million, marking a year-over-year increase of 3130.02%. This contributed to the annual value of -$26.4 million for FY2024, which is 1690.58% up from last year.
  • Definitive Healthcare's Cash from Investing Activities amounted to $24.1 million in Q3 2025, which was up 16940.07% from -$10.2 million recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Cash from Investing Activities ranged from a high of $83.5 million in Q1 2025 and a low of -$166.9 million during Q1 2022
  • Over the past 5 years, Definitive Healthcare's median Cash from Investing Activities value was -$4.0 million (recorded in 2022), while the average stood at -$13.5 million.
  • As far as peak fluctuations go, Definitive Healthcare's Cash from Investing Activities tumbled by 424284.23% in 2022, and later surged by 101447.76% in 2024.
  • Over the past 5 years, Definitive Healthcare's Cash from Investing Activities (Quarter) stood at -$41.1 million in 2021, then tumbled by 65.3% to -$67.9 million in 2022, then surged by 180.14% to $54.4 million in 2023, then tumbled by 148.28% to -$26.3 million in 2024, then soared by 191.9% to $24.1 million in 2025.
  • Its Cash from Investing Activities was $24.1 million in Q3 2025, compared to -$10.2 million in Q2 2025 and $83.5 million in Q1 2025.